Genetic variations in bile acid homeostasis are not overrepresented in alcoholic cirrhosis compared to patients with heavy alcohol abuse and absent liver disease

Mutagenesis

Volumn 27, Issue 5, 2012, Pages 567-572

  Many, Natalie ^a   Stickel, Felix ^b   Schmitt, Johannes ^a   Stieger, Bruno ^a,c   Soyka, Michael ^d,e   Frei, Pascal ^a   Götze, Oliver ^a   Müllhaupt, Beat ^a   Geier, Andreas ^a,c,f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Private Hospital Meiringen Willigen   (Switzerland)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILE ACID; BILE SALT; BILIRUBIN; VITAMIN D RECEPTOR;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; COMPARATIVE STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMEOSTASIS; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALCOHOLISM; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HOMEOSTASIS; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 84867327003     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ges020     Document Type: Article

References (38)

1. WHO (2011) Global Status Report on Alcohol and Health. World Health Organization, Geneva, Switzerland, p. 85.
2. Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. and Bell, B. P. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol., 45, 529-538.
3. Altamirano, J. and Bataller, R. (2011) Alcoholic liver disease: pathogenesis and new targets for therapy. Nat. Rev. Gastroenterol. Hepatol., 8, 491-501.
4. Raynard, B., Balian, A., Fallik, D., Capron, F., Bedossa, P., Chaput, J. C. and Naveau, S. (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology, 35, 635-638.
5. Becker, U., Deis, A., Sørensen, T. I., Grønbaek, M., Borch-Johnsen, K., Müller, C. F., Schnohr, P. and Jensen, G. (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology, 23, 1025-1029.
6. Wilfred de Alwis, N. M. and Day, C. P. (2007) Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin. Liver Dis., 27, 44-54.
7. Stickel, F. and Hampe, J. (2012) Genetic determinants of alcoholic liver disease. Gut, 61, 150-159.
8. Lucey, M. R., Mathurin, P. and Morgan, T. R. (2009) Alcoholic hepatitis. N. Engl. J. Med., 360, 2758-2769.
9. Miller, A. M., Horiguchi, N., Jeong, W. I., Radaeva, S. and Gao, B. (2011) Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin. Exp. Res, 35, 787-793.
10. Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I. and Thurman, R. G. (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology, 117, 942-952.
11. McClain, C. J., Song, Z., Barve, S. S., Hill, D. B. and Deaciuc, I. (2004) Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G497-G502.
12. Geier, A., Dietrich, C. G., Voigt, S., Kim, S. K., Gerloff, T., Kullak- Ublick, G. A., Lorenzen, J., Matern, S. and Gartung, C. (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology, 38, 345-354.
13. Tung, B. Y. and Carithers, R. L. (1999) Cholestasis and alcoholic liver disease. Clin. Liver Dis., 3, 585-601.
14. Mills, P. R., Meier, P. J., Smith, D. J., Ballatori, N., Boyer, J. L. and Gordon, E. R. (1987) The effect of changes in the fluid state of rat liver plasma membrane on the transport of taurocholate. Hepatology, 7, 61-66.
15. Gregory, D. H., Vlahcevic, Z. R., Prugh, M. F. and Swell, L. (1978) Mechanism of secretion of biliary lipids: role of a microtubular system in hepatocellular transport of biliary lipids in the rat. Gastroenterology, 74, 93-100.
16. Zollner, G., Fickert, P., Zenz, R. et al. (2001) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology, 33, 633-646.
17. Trinchet, J. C., Gerhardt, M. F., Balkau, B., Munz, C. and Poupon, R. E. (1994) Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features. J. Hepatol., 21, 235-240.
18. Nissenbaum, M., Chedid, A., Mendenhall, C. and Gartside, P. (1990) Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119. Dig. Dis. Sci., 35, 891-896.
19. Montet, A. M., Oliva, L., Beaugé, F. and Montet, J. C. (2002) Bile salts modulate chronic ethanol-induced hepatotoxicity. Alcohol Alcohol., 37, 25-29.
20. Schmidt, D. R., Holmstrom, S. R., Fon Tacer, K., Bookout, A. L., Kliewer, S. A. and Mangelsdorf, D. J. (2010) Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem., 285, 14486-14494.
21. Malik, P., Gasser, R. W., Kemmler, G., Moncayo, R., Finkenstedt, G., Kurz, M. and Fleischhacker, W. W. (2009) Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin. Exp. Res., 33, 375-381.
22. Shankar, K., Liu, X., Singhal, R., Chen, J. R., Nagarajan, S., Badger, T. M. and Ronis, M. J. (2008) Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1, 25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). Endocrinology, 149, 1748-1756.
23. Nagpal, S., Na, S. and Rathnachalam, R. (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev., 26, 662-687.
24. Stickel, F., Osterreicher, C. H., Halangk, J. et al. (2008) No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. Alcohol Clin. Exp. Res., 32, 959-965.
25. Treutlein, J., Cichon, S., Ridinger, M. et al. (2009) Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry, 66, 773-784.
26. Stickel, F., Buch, S., Lau, K. et al. (2011) Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology, 53, 86-95.
27. Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A. and Van Leeuwen, J. P. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156.
28. Roda, A., Kricka, L. J., DeLuca, M. and Hofmann, A. (1982) Bioluminescence measurement of primary bile acids using immobilized 7 alpha-hydroxysteroid dehydrogenase: application to serum bile acids. J. Lipid Res., 23, 1354-1361.
29. Iwata, R. et al. (2011) A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin. Sci. (Lond.), 120, 287-296.
30. Baur, K., Baur, K., Stieger, B. et al. (2012) Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int, 32, 635-643.
31. Meier, Y., Zodan, T., Lang, C., Zimmermann, R., Kullak-Ublick, G. A., Meier, P. J., Stieger, B. and Pauli-Magnus, C. (2008) Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptiveinduced cholestasis in carriers of the 1331T.C polymorphism in the bile salt export pump. World J. Gastroenterol., 14, 38-45.
32. Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G. and Hinds, D. A. (2010) Variant in PNPLA3 is associated with alcoholic liver disease. Nat. Genet., 42, 21-23.
33. Stieger, B., Meier, Y. and Meier, P. J. (2007) The bile salt export pump. Pflugers Arch., 453, 611-620.
34. Meier, Y., Pauli-Magnus, C., Zanger, U. M. et al. (2006) Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology, 44, 62-74.
35. Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak- Ublick, G. A., Meier, P. J. and Pauli-Magnus, C. (2007) Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet. Genomics, 17, 47-60.
36. Valdivielso, J. M. and Fernandez, E. (2006) Vitamin D receptor polymorphisms and diseases. Clin. Chim. Acta, 371, 1-12.
37. Vogel, A., Strassburg, C. P. and Manns, M. P. (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology, 35, 126-131.
38. Falleti, E., Bitetto, D., Fabris, C. et al. (2010) Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J. Gastroenterol., 16, 3016-3024.